This protocol is judged by an institutional critique board, an impartial group that testimonials any clinical trials involving people. If a study will involve a Schedule I drug, once the board approves the protocol as ethical, the researchers have to make an application for an investigational new drug (IND) number from your FDA.“It’s crucial t